Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valrubicin +/- BCG in Superficial Bladder Cancer
NCT00003759Phase 2Completed
- Sponsor
- Anthra Pharmaceuticals, Inc.
- Start
- Nov 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valrubicin in bladder cancer, sponsored by Anthra Pharmaceuticals, Inc.. Started Nov 1998; status: completed.
02
Drugs
valrubicin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00003759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003759.